MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    A case of levodopa responsive rapid onset dystonia-parkinsonism

    Y. Fernandez, S. Frucht (New York, NY, USA)

    Objective: We describe and demonstrate by video a young man with rapid onset dystonia parkinsonism who has a robust response to levodopa. Background: Rapid onset…
  • 2018 International Congress

    Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

    A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

    Objective: To investigate the impact of environmental factors on eye movement performances in two populations composed of carefully selected healthy subjects with strikingly different ethnic…
  • 2018 International Congress

    Spatial correlation and segregation of multimodal MRI abnormalities in multiple system atrophy

    J.H. Lee, M.J. Lee, T.H. Kim (Yangsan-si, Gyeongsangnam-do, Republic of Korea)

    Objective: This study aimed to quantify spatial patterns of multimodal MRI abnormalities in basal ganglia (BG) and brainstem-cerebellar (Stem-CB) regions and define structural MRI findings…
  • 2018 International Congress

    Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

    J. Massa, L. Chahine (Pittsburgh, PA, USA)

    Objective: To describe the characteristics of patients initially diagnosed with idiopathic Parkinson’s Disease (PD) and with abnormal dopamine transporter (DAT) imaging who have a change…
  • 2018 International Congress

    Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy

    K.W. Park, EJ. Lee, N.R. Choi, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

    Objective: To investigate the pupillary autonomic function and oculomotor characteristics of patients with multiple system atrophy (MSA). Background: MSA is a debilitating neurodegenerative disorder with…
  • 2018 International Congress

    Motor and cognitive deficits in a mouse model of tauopathy with tau isoforms imbalance: Potential therapeutic strategies

    ME. Avale, SL. Espindola, A. Damianich, M. Sartor, J. Ferrario (Buenos Aires, Argentina)

    Objective: This work investigates motor phenotypes and neurochemical changes in a mouse model of tauopathy linked to tau mis-splicing. We sought to validate a potential…
  • 2018 International Congress

    Diffusion magnetic resonance imaging for predicting the severity of Progressive supranuclear palsy

    X.A. Zhao, S.H. Lin, C.C. Tsai, Y.M. Wu, W.Y. Lin, Y.H. Weng, L.S. Lu, Y.L. Chen, J.J. Wang (Taoyuan City, Taiwan)

    Objective: The current study proposed to build a prediction model of clinical severity from the combination of multiple diffusion tensor derived indices in patients with…
  • 2018 International Congress

    Olfactory testing in Parkinson plus syndromes

    O. Abdukarimov, F. Akhmedova (Tashkent, Uzbekistan)

    Objective: To determine the diagnostic utility of olfactory testing in patients with neurodegenerative Parkinsonism. Background: Olfactory dysfunction can be identified in the vast majority of…
  • 2018 International Congress

    Progressive Supranuclear Palsy and Eye of the Tiger Sign

    O. Dogu, H. Genç, N. Öksüz (Mersin, Turkey)

    Objective: To report a typical progressive supranuclear palsy case with "eye of the tiger sign" on MRI Background: Progressive supranuclear palsy (PSP); is a degenerative…
  • 2018 International Congress

    PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

    J. Levin, S. Maass, M. Schuberth, A. Giese, W. Oertel, W. Poewe, C. Trenkwalder, G. Wenning, U. Mansmann, M. Suedmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Loehle, J. Classen, A. Muenchau, J. Kassubeck, G. Ebersbach, D. Berg, S. Egert, C. Eberhardt, F. Paul, K. Boetzel, B. Ertl-Wagner, H. Huppertz, I. Ricard, G. Hoeglinger (Munich, Germany)

    Objective: To evaluate the safety and tolerability of epigallocatechin gallate (EGCG) in high doses and its efficacy to slow down disease progression in patients with…
  • « Previous Page
  • 1
  • …
  • 1106
  • 1107
  • 1108
  • 1109
  • 1110
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley